trophy-u-01: sacituzumab govitecan in patients with muc after failure of platinum-based regimens...
Published 4 years ago • 106 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
2:38
trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
-
2:07
trophy-u-01: sacituzumab govitecan for platinum-ineligible metastatic uc
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
2:17
tricuspid valve in valve implantation: myval balloon expandable valve in epic bioprosthetic valve
-
25:40
ct of cardiac masses: pearls and pitfalls - part 2
-
14:47
sacituzumab govitecan clinical pearl
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
2:30
final os results of imvigor130: atezolizumab plus platinum/gemcitabine for muc
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
6:01
sacituzumab govitecan given accelerated fda approval for advanced urothelial cancer
-
1:38
dr. tagawa on sacituzumab govitecan in urothelial carcinoma
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study
-
9:50
ss08 foregut ii: s036 decreasing morbidity and mortality in one hundred consecutive esophagectomies
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
2:01
petros grivas, md, phd, on whether the results of trophy-u-01 justify a larger phase iii study
-
12:06
3. value assessment for patients who underwent minimally invasive vs open colectomies at a tertiary
-
13:50
a. manginas | guidelines and classification of bioprothetic tavr and savr dysfunction and failure.
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
25:23
tavr: evolution and vascular implications